1. Vietnam Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Vietnam Medical and Pharmaceutical Investment Joint Stock Company

Vietnam Medical and Pharmaceutical Investment Joint Stock Company

HHOSE:JVC
2,850.00
VND
-40.00
(-1.38%)
-104.59EPS
343.13BMarket Cap
2009 Y
2010 Y
2012 Y
2013 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
17,634.98
40,661.78
20,674.38
9,922.14
8,253.58
4,239.02
4,439.39
4,817.92
5,467.32
4,597.09
3,657.03
3,477.58
4,221.21
Basic EPS, GAAP
3,211.13
7,384.88
4,616.04
696.16
1,661.68
-12,006.2
-350.73
79.32
101.74
24.85
-681.65
-266.16
-104.07
Free Cash Flow per Basic Share
-3,038.96
-19,990.12
-11,577.53
-1,066.28
-513.62
-2,627.41
676.68
456.95
199.7
73.34
766.34
95.36
310.68
Dividend per Share
- -
- -
1,313.62
- -
252.53
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
716.34
4,465.74
10,763.49
14,683.59
16,586.78
4,579.52
4,595.22
4,596.76
4,698.5
4,723.35
4,041.7
3,775.54
3,920.83
Tangible Book Value per Share
716.34
4,465.74
10,763.35
14,617.75
16,585.94
4,578.86
4,594.74
4,594.14
4,693.07
4,720.22
4,013.18
3,754.85
3,905.02
Basic Weighted Avg Shares
10
10
37
60
113
113
113
113
113
113
113
113
115
Sales/Revenue/Turnover
182,915
421,755
761,740
594,056
928,529
476,890
499,432
542,017
615,074
517,173
411,417
391,228
485,107
Operating Margin (%)
24.5
25.77
34.95
22.87
28.93
-281.94
-7.06
2.49
0.09
-2.28
-18.21
-9.75
-4.76
Depreciation Expense
30,965
44,960
56,748
70,400
60,129
66,748
69,665
69,397
71,377
78,199
107,126
83,795
60,034
Net Income, GAAP
33,307
76,598
170,076
41,680
186,939
-1,350,699
-39,457
8,923
11,446
2,796
-76,686
-29,943
-11,960
Effective Tax Rate (%)
17.5
25.05
25.04
32.05
23.61
- -
- -
1.62
5.61
- -
- -
- -
- -
Profit Margin (%)
18.21
18.16
22.33
7.02
20.13
-283.23
-7.9
1.65
1.86
0.54
-18.64
-7.65
-2.47
Working Capital
-148,334
104,142
407,922
545,724
1,510,728
160,313
100,046
126,410
176,843
236,831
143,878
156,490
240,258
LT Debt
7,459
7,958
18,063
33,123
98,622
37,417
22,104
7,882
- -
- -
3,978
2,198
863
Total Equity
46,417
289,368
697,444
951,456
1,866,016
515,197
516,963
517,136
528,582
531,378
454,692
424,976
441,285
Return on Invested Capital (%)
- -
30.32
20.6
4.22
9.07
- -
- -
-3.24
0.36
- -
- -
- -
- -
Return on Capital (%)
- -
35.91
26.61
6.16
12.18
- -
- -
2.19
2.35
- -
- -
- -
- -
Return on Common Equity (%)
- -
45.62
34.47
5.06
13.27
-113.45
-7.65
1.73
2.19
0.53
-15.55
-6.81
-2.46

Capital Structure

VND

•

in mil. unless spec.
Jun'23
Sep'23
Dec'23
ST Debt
54,416
39,925
42,120
LT Borrowings
1,753
1,308
863
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
113
113
113
Market Capitalization
564,751
533,251
343,126

Working Capital

VND

•

in mil. unless spec.
Jun'23
Sep'23
Dec'23
Total Current Assets
331,126
357,238
382,149
Cash, Cash Equivalents & STI
152,453
182,242
175,211
Accounts Receivable, Net
423,719
419,061
421,481
Inventories
60,169
53,291
64,850
Total Current Liabilities
115,103
124,609
141,890
Payables & Accruals
- -
- -
- -
ST Debt
54,416
39,925
42,120
Deferred Revenue
- -
- -
- -

Growth Rates

VND

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.33%
-3.64%
-6.54%
Free Cash Flow
100.23%
141.06%
-87.56%
Net Income, GAAP
-359.81%
-614.71%
-60.95%
Sales/Revenue/Turnover
5.17%
-3.85%
-4.91%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
90,580
106,797
- -
- -
411,417
2022
98,025
108,108
96,531
88,766
391,228
2023
101,689
143,817
150,836
- -
- -

Quarterly Earnings Per Share

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-6
9
- -
- -
-681.65
2022
-3.23
-21
-2
-240.22
-266.16
2023
27.43
94
12
- -
- -

Quarterly Dividends Per Share

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Chung Minh Le
Full Time Employees
165
Sector
Distribution services
Industry
Medical distributors
Address
Ha Noi Vietnam
IPO Date
Jun 1, 2011
Website
ytevietnhat.com.vn
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
McKesson Corporation (NYSE:MCK)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Vietnam Medical and Pharmaceutical Investment Joint Stock Company, formerly known as Japan Vietnam Medical Instrument Joint Stock Company and Japan Vietnam Medical Investment and Development Joint Stock Company, is a Vietnam-based healthcare enterprise primarily engaged in the distribution of medical equipment, provision of medical consumables, delivery of healthcare and technical maintenance services, and investment in pharmaceutical and clinical operations. Founded in 2001 and headquartered in Hanoi, Vietnam, with a regional branch in Ho Chi Minh City, the company operates across the domestic healthcare sector serving public and private hospitals, diagnostic centers, medical clinics, corporate enterprises, and individual patients. The company operates through four principal business segments: Medical Equipment Distribution, Consumables and Supplies, Technical and Engineering Services, and Healthcare Services. In collaboration with global manufacturers including Hitachi, Fujifilm, Konica Minolta, Carestream Health, Toray, Pentax, Endomed, Sakura Seiki, Nemoto Kyorindo, DRGEM, MELAG, Novaerus, and Saraya, the company supplies advanced diagnostic imaging equipment; magnetic resonance imaging (MRI) scanners, computed tomography (CT) systems, digital radiography X-ray machines, positron emission tomography (PET/CT) systems, ultrasound devices, and flexible endoscopy systems; general medical devices; patient monitors, anesthesia workstations, surgical suites, and infection control and sterilization systems; medical consumables and diagnostic supplies; radiographic films, contrast media injectors, diagnostic reagents, disposables, and hospital hygiene products; equipment lifecycle services; installation, warranty maintenance, equipment calibration, technical training, repair, and refurbishment; healthcare equipment leasing and placement arrangements; and healthcare delivery services; comprehensive outpatient care via its Viet Nhat Clinic, general health screenings, specialized medical diagnostics, dental services, home healthcare, and mobile health examination services utilizing a fleet of specialized medical examination buses. In recent corporate developments, the company officially changed its name to Vietnam Medical and Pharmaceutical Investment Joint Stock Company following resolutions passed at its November 2025 Extraordinary General Meeting of Shareholders, marking a strategic expansion into pharmaceutical distribution, trading, and healthcare investment. To support this strategic pivot and long-term objective of reaching VND 934 billion in consolidated revenue by 2028, the company amended its registered business scope, approved plans for private placement equity financing to support medical leasing and equipment projects, expanded its Board of Directors with independent leadership for the 2021–2026 tenure, and established new medical equipment distribution and technical service agreements with regional healthcare providers, including An Phuoc General Hospital.